Loading data
URGNNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 109.79 m USD | 90.4 m USD | 82.71 m USD | 64.36 m USD | 48.04 m USD |
| Cost of revenue | 12.45 m USD | 8.88 m USD | 9.36 m USD | 7.65 m USD | 5.16 m USD |
| Gross profit | 97.34 m USD | 81.52 m USD | 73.35 m USD | 56.7 m USD | 42.89 m USD |
| Research and development expense | 67.11 m USD | 57.15 m USD | 45.61 m USD | 52.91 m USD | 47.64 m USD |
| Selling, general and administrative expense | 155.1 m USD | 121.15 m USD | 93.27 m USD | 82.84 m USD | 87.54 m USD |
| Operating profit | -124.86 m USD | -96.78 m USD | -65.54 m USD | -79.04 m USD | -92.29 m USD |
| Profit before tax | -153.42 m USD | -124.04 m USD | -98.32 m USD | -108.03 m USD | -109.37 m USD |
| Income tax expense | 78 k USD | 2.83 m USD | 3.92 m USD | 1.76 m USD | 1.45 m USD |
| Net income (reported basis) | -153.49 m USD | -126.87 m USD | -102.24 m USD | -109.78 m USD | -110.82 m USD |
| Basic earnings per share | -3.19 USD/share | -2.96 USD/share | -3.55 USD/share | -4.81 USD/share | -4.96 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.